Report Interpretation
HSBC expects Robotechnik’s acquisition of ficonTEC to transform it from solar automation into a photonics assembly and testing equipment supplier. The report forecasts a 330% 2026-28e net-profit CAGR and sets a PEG-based RMB758.00 target price.
Summary
HSBC initiates Robotechnik at Buy on a ficonTEC-driven shift into high-growth photonics
HSBC expects Robotechnik’s acquisition of ficonTEC to transform it from solar automation into a photonics assembly and testing equipment supplier. The report forecasts a 330% 2026-28e net-profit CAGR and sets a PEG-based RMB758.00 target price.
- Photonics is projected to rise from 46% of 2025 revenue to 87% of sales in 2028e.
- Optoelectronic backlog reached RMB2,452m at end-June 2026, or 72% of total backlog.
- HSBC expects 2027 to be the earnings inflection point, with net profit growth of 518% year-on-year.
- The target price of RMB758.00 implies about 37% upside from the RMB552.11 share price as of 27 August 2026.
- Key risks include slower CPO commercialisation, AI capex cuts, alternative technologies, geopolitics and price competition.
Report Interpretation
Overview
HSBC initiates coverage of Robotechnik with a Buy rating, viewing its 2025 acquisition of ficonTEC as a strategic shift into high-margin photonics manufacturing equipment. The central thesis is that rising demand for optical assembly and testing equipment ahead of co-packaged optics mass production can drive a sharp improvement in revenue mix, margins and earnings through 2028e.
Core views
HSBC argues that Robotechnik’s investment case has shifted from its legacy solar-cell automation business to photonics. The company completed the RMB1bn acquisition of German photonics equipment maker ficonTEC in May 2025, gaining automated assembly, coupling and testing capabilities for specialised optical components. HSBC identifies customers including TSMC, Broadcom, Nvidia and Valeo, and sees the acquisition as positioning Robotechnik in the photonic manufacturing value chain as advanced optical packaging moves toward high-volume production. It expects optoelectronic equipment to become the main earnings driver, accounting for 87% of 2028e sales versus 46% in 2025, while solar-cell automation revenue remains broadly flat amid softer China solar demand. The report’s industry logic centres on the manufacturing difficulty of advanced photonics. Optical components require very tight placement tolerances, active alignment, fibre handling and high-throughput testing to preserve coupling efficiency and production yield. HSBC explains that fibre-coupling machines can represent up to 40% of a photonic production line’s value and testers about 27%. ficonTEC’s claimed differentiation is its integrated combination of sub-micron accuracy, active alignment, motion control, automation, bonding, fibre handling and process-control software. HSBC considers this end-to-end capability hard to replicate and especially valuable as customers seek repeatable high-volume production rather than low-volume prototypes. Testing is a further growth opportunity. HSBC describes insertion 2 and insertion 3 tests as difficult stages requiring simultaneous electrical and optical probing, nanometre-level positioning and fast active alignment. Robotechnik announced on 21 July 2026 that its insertion 2 and 3 equipment was already in mass production and shipping to customers, while insertion 4 equipment remained under development. The institution believes the company has a particular advantage in double-sided wafer-level and die-level optical testing because it can apply its multi-axis sub-micron alignment capabilities. This is relevant because the report expects testing demand to rise as customers move toward more integrated photonic devices. Order momentum is presented as early commercial validation and as a source of earnings visibility. Robotechnik announced aggregate optoelectronic orders of RMB1.7bn year-to-date in 2026, versus RMB358m in 2025. At end-June 2026, its optoelectronic backlog was RMB2,452m, representing 72% of total backlog, compared with RMB934m for the legacy solar business. HSBC believes these orders support 2027 revenue before the anticipated broader photonic mass-production ramp from 2028. It expects this combination of customer engagement, ecosystem partnerships and order visibility to create a 2027 earnings inflection point. HSBC forecasts total revenue of RMB1,244m in 2026e, RMB2,298m in 2027e and RMB4,054m in 2028e, equivalent to a 62% 2025-28e revenue CAGR. It expects optoelectronic equipment revenue to grow 60% in 2026e, 150% in 2027e and 100% in 2028e as coupling, assembly and test-machine shipments increase. The report forecasts gross margin rising from 34.5% in 2025 to 49.7% in 2028e as higher-margin photonics equipment becomes a larger part of sales and scale effects emerge. Net profit is forecast to move from a RMB66m loss in 2025 to RMB45m in 2026e, RMB276m in 2027e and RMB825m in 2028e; HSBC forecasts a 330% 2026-28e net-profit CAGR and 518% year-on-year profit growth in 2027e. The report frames 2027-28 as the key timing window for CPO. Its scenario work assumes 61m CPO units in 2030e in the bull case and estimates the 2030 photonic assembly-equipment market at RMB30bn and the testing-equipment market at RMB51bn. At a 10% market share, Robotechnik’s implied revenue would be RMB8bn in the bull case. In the bear case, where co-packaging fails to scale in 2030, implied revenue falls to RMB4.8bn, which HSBC says would also prompt a valuation de-rating. The report considers slower-than-expected advanced photonic packaging commercialisation the largest medium-term downside risk. HSBC uses PEG valuation because it does not regard Robotechnik’s historical solar-automation PE as a suitable reference for its future photonics potential. Global peers trade at an average 0.7x PEG based on average 2027-28 consensus PE of 26x and 36% 2026-28e EPS CAGR. Applying a 231x PE implied by HSBC’s 330% net-profit CAGR to average 2027-28e EPS of RMB3.29 produces a RMB758.00 target price, implying about 37% upside. A sum-of-the-parts cross-check produces RMB613 per share, still implying 18% upside. HSBC also notes that Robotechnik traded at 0.6x 2027e PEG, 30% below the global peer average of 0.9x, despite a 137% year-to-date share-price rise and subsequent volatility.
Analysis framework
HSBC starts with Robotechnik’s business transformation following the ficonTEC acquisition, then explains the optical assembly and testing bottlenecks that make the acquired capabilities valuable. It uses order announcements and backlog to assess near-term demand visibility, models segment revenue, margins, costs and earnings through 2028e, and develops 2030 bull and bear scenarios for photonics equipment demand. Valuation is based primarily on PEG relative to global peers and is cross-checked with a sum-of-the-parts approach.
Methodology notes
PEG-based valuation
HSBC relates an earnings-growth forecast to a PE multiple. It applies a 231x PE implied by its 330% 2026-28e net-profit CAGR to average 2027-28e EPS of RMB3.29 to derive the RMB758.00 target price.
Sum-of-the-parts cross-check
The report values the optoelectronic and legacy solar equipment businesses separately using different profit-margin and PE assumptions, then combines them with net cash to derive RMB613 per share.
Photonics manufacturing value-chain analysis
The report links AI data-centre and CPO adoption to demand for optical coupling, assembly and testing equipment, then to Robotechnik’s orders, revenue mix and margins.
2030 equipment market scenario build
HSBC estimates equipment demand using transceiver or CPO volumes, optical engines per unit, machine throughput, utilisation, yield, required equipment sets, average selling prices and assumed market share.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Robotechnik (300757.SZ)Primary covered company; HSBC expects it to benefit from demand for high-volume photonic coupling, assembly and testing equipment.
- Strengths
- ficonTEC provides over 20 years of photonics expertise, more than 1,000 installed machines, integrated active-alignment and testing capabilities, ecosystem partnerships and support from Robotechnik’s manufacturing scale.
- Weaknesses
- The company relies on third-party mechanical components and motion controllers rather than producing them in-house.
- Comparison
- HSBC views Robotechnik as a more specialised player than larger electronic equipment companies entering photonics; it trades at 0.6x 2027e PEG versus a 0.9x global-peer average.
- Risks
- Alternative coupling technologies, slower CPO mass production, AI capex cuts, geopolitical restrictions and intensified equipment price competition.
- ficonTECWholly owned subsidiary and the source of Robotechnik’s photonics assembly, coupling and testing capabilities.
- Strengths
- Global market-leading position in automated high-precision optical-component assembly, coupling and testing; broad turnkey product portfolio and established European ecosystem.
- Comparison
- HSBC considers its integrated capability difficult to replicate in a specialised field with few end-to-end competitors.
- Risks
- Scaling demand depends on the pace of photonic mass production and customer adoption.
Key data
- Target priceRMB758.00PEG-based target price, implying about 37% upside.
- Share priceCNY552.11As of 27 August 2026.
- Optoelectronic backlogRMB2,452mAt end-June 2026; 72% of total backlog.
- 2026 year-to-date optoelectronic ordersRMB1.7bnVersus RMB358m in 2025.
- Revenue forecastRMB1,244m / RMB2,298m / RMB4,054m2026e / 2027e / 2028e; 62% 2025-28e revenue CAGR.
- Net-profit forecastRMB45m / RMB276m / RMB825m2026e / 2027e / 2028e; 330% 2026-28e CAGR.
- Gross-margin forecast49.7%2028e, versus 34.5% in 2025.
- Photonics sales mix87%Expected share of 2028e sales, versus 46% in 2025.
- SOTP value per shareRMB613Cross-check, implying 18% upside.
Impact & implications
HSBC sees ficonTEC’s technology, customer access and photonics manufacturing expertise as changing Robotechnik’s earnings mix and growth profile. In its view, order conversion and a 2027-28 CPO ramp could improve earnings visibility and support a valuation re-rating, while delayed commercialisation would materially weaken the projected outcome.
Risks
- Alternative optical coupling and assembly technologies, including high-throughput micro-optical fabrication, glass bridge and nano 3D printing, could reduce demand for Robotechnik’s equipment.
- AI data-centre capex cuts could reduce equipment demand from overseas hardware customers.
- Geopolitical tensions between China and the US could restrict market access and disrupt revenue growth.
- Advanced photonic packaging may commercialise and reach mass production more slowly than HSBC expects, reducing 2028 revenue and profit and triggering a de-rating.
- More intense pricing competition in photonic assembly and testing equipment could compress gross margin.
- Technical bottlenecks or lower-than-expected yield could encourage customers to use alternative approaches or develop equipment in-house.
What to watch
- Further optoelectronic order wins and conversion of the RMB2,452m end-June 2026 backlog.
- 3Q26 results relative to expectations, which HSBC identifies as a potential share-price catalyst.
- Progress in high-volume CPO and advanced photonic packaging shipments, especially the anticipated 2027-28 inflection.
- Commercial uptake of Robotechnik’s insertion 2 and insertion 3 testing equipment and development progress for insertion 4.
- The pace of photonics revenue mix expansion, gross-margin improvement and scale effects.
- AI data-centre capital spending and changes in the competitive landscape for optical assembly and testing equipment.